Medical Devices

COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015 - 2022

  • ALL152427
  • 145 Pages
  • August 2016
  • Medical Devices
Download Sample    Get Discount   
 

COPD and asthma devices, also known as pulmonary drug delivery devices, are used as a permanent treatment or rescue therapy for respiratory diseases and other related ailments. It is the most advanced mode of drug administration in which the drug is directly delivered to the lungs to provide a systemic effect. COPD and asthma have significant shares in the global respiratory diseases market. According to the Global Initiative for Asthma (GINA), around 300 million people across the world suffer from asthma every year. COPD, being the 3rd leading cause for death, led to the death of 3 million people in 2013. Thus, a variety of drug-delivery protocols, such as oral and parenteral delivery, are developed for the treatment of COPD and asthma. However, the pulmonary drug delivery system is the most effective treatment option as compared to the other conventional methods.

The world COPD and asthma devices market is expected to reach $41,355.2 million by 2022. The major factors driving the market growth include increasing awareness for respiratory diseases, such as asthma and emphysema, and rising incidence of respiratory diseases caused due to cigarette consumption. The growth of the market would be boosted due to increase in healthcare expenditure, growth in the use of automation in healthcare industry, and rapid adoption of advanced medical solutions. Currently, most of healthcare practitioners and pulmonary diseases specialists prefer a combination of a drug and a device, for instance inhaler and nebulizer, owing to its fast and effective outcome. However, the market growth could be hindered due to high cost associated with nebulizers, side effects occurring due to excessive dosage, and lack of awareness regarding drug inhalation.

The world COPD and asthma devices market is segmented based on product device type and geography. Based on the product device type, the market is segmented into inhalers and nebulizers. Inhalers segment is projected to grow at a CGAR of 5.3% during the study period. Furthermore, the inhalers segment includes dry powder inhalers (DPIs), metered dose inhalers (MDIs), and soft mist inhalers (SMIs). The nebulizers segment includes compressor nebulizers, ultrasonic nebulizers, and mesh nebulizers. Based on geography, the market is categorized into North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of respective countries. Within Europe region, Germany, France and U.K. accounted for more than 40% of market share in 2015.

The leading players profiled in this report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products, Inc., Sunovion Pharmaceuticals, Inc., Boehringer Ingelheim, GF Healthcare Products, Omron Corporation, Smith Medicals, Lincare Holdings, Inc., and Baxter International.  

KEY BENEFITS

  • The market estimations in this report are based on high-end analysis of the key segments from 2015 to 2022.
  • Extensive analysis of the world COPD and asthma devices market, by product, helps in understanding the various types of devices used for the treatment of respiratory conditions.
  • This report provides comprehensive analysis of factors that drive and restrict growth of the COPD and asthma devices market.
  • Porter’s Five Forces model provides an in-depth analysis of the bargaining power of buyers and suppliers, threats of new entrants and substitutes, and competition among the key market players.
  • Competitive intelligence highlights the business practices adopted by leading market players across various geographies.
  • SWOT analyses of market players enable the study of the internal environment and strategies adopted by them.    

COPD AND ASTHMA DEVICES MARKET SEGMENTATION

The COPD and asthma devices market is segmented based on product type and geography.

By Product Types

  • Inhalers

    • Drug powder inhalers (DPIs)
    • Metered dose inhalers (MDIs)
    • Soft mist inhalers (SMIs)

  • Nebulizers

    • Compressor nebulizers
    • Ultrasonic nebulizers
    • Mesh nebulizers

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • UK
    • Germany
    • France
    • Italy
    • Russia
    • Others

  • Asia-Pacific

    • India
    • China
    • Japan
    • Australia
    • Others

  • LAMEA

    • Brazil
    • Argentina
    • Colombia
    • Saudi Arabia
    • Turkey
    • Others

CHAPTER 1 INTRODUCTION

1.1 Report description

1.2 Key benefits

1.3 Key market segments

1.4 Research methodology

1.4.1 Primary research

1.4.2 Secondary Research

1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

2.2 Market beyond what to expect by 2027

2.2.1 Moderate growth scenario

2.2.2 Rapid growth scenario

2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope

3.2 Key findings

3.2.1 Top impacting factors

3.2.2 Top investment pockets

3.2.3 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of buyers (High)

3.3.2 Bargaining power of suppliers (Low to Moderate)

3.3.3 Threat of new entrants (Low)

3.3.4 Threat of substitutes (High)

3.3.5 Intense competitive rivalry

3.4 Value chain analysis

3.5 Market share analysis, 2015

3.6 Government regulations

3.6.1 COPD devices regulations in Europe and in the U.S.

3.6.2 COPD devices regulations in Asia-Pacific

3.7 Drivers

3.7.1 Daily exposure to environmental pollution

3.7.2 Increase in population susceptible to indoor air pollutants

3.7.3 Portability of the drug delivery devices

3.7.4 Increasing population of Active smokers

3.7.5 Rising government initiatives

3.8 Restraints

3.8.1 Increasing price competition and deterioration of material quality

3.8.2 Overall high cost of asthma treatment is a challenge for the patients

3.8.3 Incompetent reimbursement support

3.9 Opportunities

3.9.1 Patent expiration for blockbuster drugs

3.9.2 Soft Mist Inhalers (SMIs): future growth driver

CHAPTER 4 WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE

4.1 Inhalers

4.1.1 Drug powdered inhalers (DPIs)

4.1.1.1 Key market trends

4.1.1.2 Key growth factors

4.1.1.3 Market size and forecast

4.1.2 Metered dose inhalers (MDIs)

4.1.2.1 Key market trends

4.1.2.2 Key growth factors

4.1.2.3 Market size and forecast

4.1.3 Soft mist inhalers

4.1.3.1 Key market trends

4.1.3.2 Key growth factors

4.1.3.3 Market size and forecast

4.2 Nebulizers

4.2.1 Compressor nebulizers

4.2.2 Ultrasonic nebulizers

4.2.3 Mesh nebulizers

CHAPTER 5 WORLD COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY

5.1 Introduction

5.2 Market size and forecast

5.3 North America

5.3.1 Key market trends

5.3.2 Market size and forecast

5.3.3 U.S

5.3.3.1 Market size and forecast

5.3.4 Canada

5.3.4.1 Market size and forecast

5.3.5 Mexico

5.3.5.1 Market size and forecast

5.4 Europe

5.4.1 Key market trends

5.4.2 Market size and forecast

5.4.3 UK

5.4.3.1 Market size and forecast

5.4.4 France

5.4.4.1 Market size and forecast

5.4.5 Germany

5.4.5.1 Market size and forecast

5.4.6 Italy

5.4.6.1 Market size and forecast

5.4.7 Russia

5.4.7.1 Market size and forecast

5.4.8 Others European countries

5.4.8.1 Market size and forecast

5.5 Asia-Pacific

5.5.1 Key market trends

5.5.2 Key growth factors and opportunities

5.5.3 Market size and forecast

5.5.4 India

5.5.4.1 Market size and forecast

5.5.5 China

5.5.5.1 Market size and forecast

5.5.6 Japan

5.5.6.1 Market size and forecast

5.5.7 Australia

5.5.7.1 Market size and forecast

5.5.1 Others

5.5.1.1 Market size and forecast

5.6 LAMEA

5.6.1 Key market trends

5.6.2 Market size and forecast

5.6.3 Brazil

5.6.3.1 Market size and forecast

5.6.4 Argentina

5.6.4.1 Market size and forecast

5.6.5 Colombia

5.6.5.1 Market size and forecast

5.6.6 Saudi Arabia

5.6.6.1 Market size and forecast

5.6.7 Turkey

5.6.7.1 Market size and forecast

5.6.8 Others

5.6.8.1 Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Glaxosmithcline PLC

6.1.1 Company overview

6.1.2 Operating business segment overview

6.1.3 Business performance

6.1.4 Key strategies move and development

6.1.5 SWOT analysis

6.2 Novartis AG

6.2.1 Company overview

6.2.2 Operating business segment overview

6.2.3 Business performance

6.2.4 Key strategies and development

6.2.5 SWOT analysis

6.3 Merck & Company

6.3.1 Operating business segment overview

6.3.2 Business performance

6.3.3 SWOT analysis

6.4 Philips Healthcare (Division of Royal Philips Company)

6.4.1 Company overview

6.4.2 Business performance

6.4.3 Strategic moves and developments

6.4.4 SWOT analysis

6.5 AstraZeneca Plc.

6.5.1 Company overview

6.5.2 Operating business segment overview

6.5.3 Business performance

6.5.4 Strategic moves and developments

6.5.5 SWOT analysis

6.6 3M Healthcare

6.6.1 Company overview

6.6.2 Business performance

6.6.3 Strategy move and development

6.6.4 SWOT analysis

6.7 GF Health Products

6.7.1 Company overview

6.7.2 Strategic moves and developments

6.7.3 SWOT analysis

6.8 Sunovion Pharmaceuticals Inc.

6.8.1 Company overview

6.8.2 Operating business segment overview

6.8.3 Business performance

6.8.4 Strategic moves and developments

6.8.5 SWOT analysis

6.9 Smith Medicals, Inc.

6.9.1 Company overview

6.9.2 Business performance

6.9.3 SWOT analysis

6.10 Baxter International

6.10.1 Company overview

6.10.2 Operating business segment overview

6.10.3 Business performance

6.10.4 SWOT analysis

6.11 Boehringer Ingelheim GmbH

6.11.1 Company overview

6.11.2 Operating business segment overview

6.11.3 Business performance

6.11.4 Key strategies and developments

6.11.5 SWOT analysis

List of Figures

FIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO, 2022-2027

FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO, 20222027

FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO, 20222027

FIG. 4 TOP FACTORS IMPACTING WORLD COPD AND ASTHMA DEVICES MARKET, 20152022

FIG. 5 TOP INVESTMENT POCKETS OF WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPES

FIG. 6 TOP WINNING STRATEGY IN COPD AND ASTHMA DEVICES MARKET, 20122016

FIG. 7 TOP WINNING STRATEGIES, BY APPLICATION, 20122016

FIG. 8 PORTERS FIVE FORCES ANALYSIS OF WORLD COPD AND ASTHMA DEVICES MARKET

FIG. 9 VALUE CHAIN ANALYSIS OF WORLD COPD AND ASTHMA DEVICES

FIG. 10 MARKET SHARE ANALYSIS OF COPD AND ASTHMA DEVICES MARKET, 2015 (%)

FIG. 11 COPD AND ASTHMA INCIDENCE IN GREAT BRITAIN, 2003-2013

FIG. 12 U.S. ASTHMA AND COPD DEVICES MARKET, 20152022 ($MILLION)

FIG. 13 CANADA COPD AND ASTHMA DEVICES MARKET, 20152022 ($MILLION)

FIG. 14 MEXICO COPD AND ASTHMA DEVICES MARKET, 20152022 ($MILLION)

FIG. 15 UK COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 16 FRANCE COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 17 GERMANY COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 18 ITALY COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 19 RUSSIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 20 REST OF EUROPEAN COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 21 INDIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 22 CHINA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 23 JAPAN COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 24 AUSTRALIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 25 REST OF APAC COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 26 BRAZIL COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 27 ARGENTINA COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 28 COLOMBIA COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 29 SAUDI ARABIA COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 30 TURKEY COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 31 OTHERS COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 32 GLAXOSMITHKLINE PLC, REVENUE 2013-2015 ($MILLION)

FIG. 33 GLAXOSMITHKLINE PLC, REVENUE BY GEOGRAPHY 2015 (%)

FIG. 34 GLAXOSMITHKLINE PLC REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 35 SWOT ANALYSIS OF GLAXOSMITHKLINE PLC

FIG. 36 NOVARTIS AG REVENUE 2013-2015 ($MILLION)

FIG. 37 NOVARTIS AG REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 38 NOVARTIS AG REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 39 SWOT ANALYSIS OF NOVARTIS AG

FIG. 40 MERCK & CO. REVENUE, 2013-2015 ($MILLION)

FIG. 41 MERCK REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 42 MERCK REVENUE BY BUSINESS UNITS, 2015 (%)

FIG. 43 SWOT ANALYSIS OF MERCK

FIG. 44 PHILIPS REVENUE, 2013-2015, ($MILLION)

FIG. 45 PHILIPS REVENUE, BY BUSINESS UNITS, 2015 (%)

FIG. 46 SWOT ANALYSIS OF PHILIPS HEALTHCARE

FIG. 47 ASTRAZENECA INC REVENUE, 2013-2015 ($MILLION)

FIG. 48 ASTRAZENECA REVENUE, BY SEGMENT 2015 (%)

FIG. 49 ASTRAZENECA REVENUYE BY GEOGRAPHY, 2013 (%)

FIG. 50 ASTRAZENECA INC. SWOT ANALYSIS

FIG. 51 3M REVENUE, 2013-2015 ($MILLION)

FIG. 52 3M REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 53 3M REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 54 SWOT ANALYSIS OF 3M

FIG. 55 SWOT ANALYSIS OF GF HEALTH PRODUCTS

FIG. 56 SUNOVION REVENUE, 2012-2015 ($MILLION)

FIG. 57 SUNOVION REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 58 SWOT ANALYSIS OF SUNOVION INC.

FIG. 59 SMITH MEDICAL INC. REVENUE, 2013-2015 ($MILLION)

FIG. 60 SMITH MEDICAL INC. REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 61 SMITH MEDICAL INC- SWOT ANALYSIS

FIG. 62 BAXTER INTERNATIONAL REVENUE, 2013-2015 ($MILLION)

FIG. 63 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 64 BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 65 SWOT ANALYSIS OF BAXTER INTERNATIONAL

FIG. 66 BOEHRINGER INGELHEIM REVENUE, 2013-2015 ($MILLION)

FIG. 67 BOEHRINGER INGELHEIM REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 68 BOEHRINGER INGELHEIM REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 69 SWOT ANALYSIS OF BOEHRINGER INGELHEIM GMBH

List of Tables

TABLE 1 WORLD COPD AND ASTHMA DEVICES MARKET, MODERATE GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 2 WORLD COPD AND ASTHMA DEVICES MARKET, RAPID GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 3 WORLD COPD AND ASTHMA DEVICES MARKET, DIMINISHING GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 4 ADVANTAGES AND DISADVANTAGES OF MARKETED PORTABLE INHALER DEVICES

TABLE 5 PERCENTAGE OF SMOKER POPULATION BY ETHNICITY, 2012

TABLE 6 TOP 10 COUNTRIES HEALTHCARE EXPENDITURE, 2013

TABLE 7 WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE, 20152022, ($MILLION)

TABLE 8 RESCUE INHALERS VS MAINTENANCE INHALERS

TABLE 9 COMMON TYPES OF INHALERS

TABLE 10 TOP 10 COPD INHALERS

TABLE 11 WORLD COPD AND ASTHMA INHALERS MARKET, BY TYPE, 2015-2022, ($MILLION)

TABLE 12 WORLD COPD AND ASTHMA INHALERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)

TABLE 13 DRY POWDER INHALERS

TABLE 14 WORLD DRY POWDER INHALERS (DPI) MARKET, BY GEOGRAPHY, 20152022, $MILLION

TABLE 15 TYPES OF METERED DOSE INHALERS (MDIS)

TABLE 16 WORLD METERED DOSE INHALERS (MDI) MARKET, BY GEOGRAPHY, 20152022, $MILLION

TABLE 17 WORLD SOFT MIST INHALERS (SMI) MARKET, BY GEOGRAPHY,

TABLE 18 2015-2022, $MILLION

TABLE 19 COMMERCIALIZED NEBULIZERS AND ITS COST

TABLE 20 WORLD NEBULIZERS MARKET, BY TYPE, 20152022, ($MILLION)

TABLE 21 WORLD NEBULIZERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)

TABLE 22 WORLD COMPRESSOR NEBULIZERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)

TABLE 23 WORLD ULTRASONIC NEBULIZERS MARKET, BY GEOGRAPHY, 20152022, ($MILLION)

TABLE 24 WORLD MESH NEBULIZERS MARKET, BY GEOGRAPHY, 20152022, ($MILLION)

TABLE 25 WORLD COPD AND ASTHMA DEVICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)

TABLE 26 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY TYPE, 2015-2022 ($MILLION)

TABLE 27 EUROPE COPD AND ASTHMA DEVICES MARKET, BY TYPE; 20152022 ($MILLION)

TABLE 28 ASIA-PACIFIC COPD DEVICES MARKET, BY TYPE, 2015-2022 ($MILLION)

TABLE 29 LAMEA COPD AND ASTHMA MARKET, BY TYPE, 2015-2022 ($MILLION)

TABLE 30 GLAXOSMITHKLINE PLC SNAPSHOT

TABLE 31 GLAXOSMITHKLINE PLC OPERATING SEGEMENTS

TABLE 32 NOVARTIS AG SNAPSHOT

TABLE 33 NOVARTIS AG OPERATING SEGEMENTS

TABLE 34 MERCK COMPANY SNAPSHOT

TABLE 35 MERCK OPERATING SEGEMENTS

TABLE 36 PHILIPS HEALTHCARE BUSINESS SNAPSHOT

TABLE 37 ASTRAZENECA INC. SNAPSHOT

TABLE 38 ASTRAZENACA INC. OPERATING SEGMENT OVERVIEW

TABLE 39 3M SNAPSHOT

TABLE 40 GF HEALTH PRODUCTS SNAPSHOT

TABLE 41 SUNOVION SNAPSHOT

TABLE 42 SUNOVION OPERATING SEGEMENTS

TABLE 43 SMITH MEDICAL INC SNAPSHOT

TABLE 44 BAXTER SNAPSHOT

TABLE 45 BOEHRINGER INGELHEIM GMBH SNAPSHOT

TABLE 46 BOEHRINGER INGELHEIM GMBH OPERATING SEGEMENTS

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370